Ansgar Schuffenhauer1, Nathan Brown, Paul Selzer
1Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland. ansgar.schuffenhauer@novartis.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Moderately complex molecules with specific structural features are ideal lead compounds for drug discovery. This study found that higher molecular complexity correlates with increased biological activity, guiding library design.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: